Arca
Skip to content
Tools
Tools

Premature birth

Drug research and approvals for premature birth: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.

As of Nov 21, 2026, 419 studies of premature birth are recruiting on ClinicalTrials.gov, and Health Canada has authorized 0 drug trials for it since 2013.

  • Recruiting worldwide: 419
  • Trials authorized in Canada: 0
  • FDA orphan approvals: 0
  • EU medicines: 0

Recruiting now

Newest posted first, of 419 recruiting on ClinicalTrials.gov ↗

Drug pipeline

Each drug at the furthest stage it has reached for this condition, from ChEMBL's drug indications

Approved 2

Phase 3 12 of 18

Phase 2 12 of 23

Phase 1 or earlier 12 of 14

How its trials ended

2,324 ClinicalTrials.gov studies of the condition, classified by TrialPanorama, partly automatically, so some labels are wrong

Of the 411 whose ending is known, 34% met their primary endpoint, 15% missed it and 51% stopped early.

  • Completed, result not reported1,02544%
  • Ongoing46720%
  • Status unknown42118%
  • Met its primary endpoint1386%
  • Stopped: other or unclear1205%
  • Stopped: enrollment or feasibility663%
  • Missed its primary endpoint623%
  • Stopped: lack of efficacy10<1%
  • Stopped: sponsor or business decision9<1%
  • Stopped: funding4<1%
  • Stopped: safety2<1%

Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA

Esc

Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.